Abstract:Background: This study aimed to investigate the effects of oral administration of Enterococcus faecium NCIMB10415（E. faecium） on intestinal development, immunological parameters and gut microbiota of neonatal piglets challenged with enterotoxigenic Escherichia coli K88（ETEC）. A total of 96 1-day-old sow-reared piglets were randomly assigned to 2 groups, with 48 piglets in each group. The piglets were from 16 litters（6 piglets each litter）,and 3 piglets each litter were allocated to the E. faecium-supplemented（PRO） group, while the other 3 piglets were allocated to the control（CON） group. After colostrum intake, piglets in the PRO group were orally administrated with 3 × 10~9 CFU E. faecium per day for a period of one week. On day 8, one piglet per litter from each group was challenged（CON+ETEC, PRO+ETEC） or not（CON-ETEC, PRO-ETEC） with ETEC in a 2 × 2 factorial arrangement of treatments. On day 10（2 days after challenge）, blood and tissue samples were obtained from piglets.Results: Before ETEC challenge, there were no significant differences for the average daily gain（ADG） and fecal score between the two groups of piglets. After ETEC challenge, the challenged piglets had greater fecal score compared to the non-challenged piglets, whereas E. faecium administration was able to decrease the fecal score.Piglets challenged with ETEC had shorter villous height, deeper crypt depth, and reduced number of goblet cells in the jejunum and decreased m RNA abundance of claudin-1 in the ileum, whereas increased the percentage of lymphocytes, concentrations of IL-1β in the plasma and TNF-α in the ileal mucosa, as well as increased the m RNA abundances of innate immunity-related genes in the ileum tissue. These deleterious effects caused by ETEC were partly alleviated by feeding E. faecium. In addition, piglets in PRO-ETEC group had decreased the percentage of CD8 + T cells of the peripheral blood when compared to those in CON-ETEC group. Moreover, E. faecium administration increased Verrucomicrobia at phylum level and decreased Bilophila at genus level.Conclusions: These results suggest that oral administration of E. faecium alleviated the intestinal injury and diarrhea severity of neonatal piglets challenged by ETEC, partly through improving the intestinal microbiota and immune response. This offers a potential strategy of dietary intervention against intestinal impairment by ETEC in neonatal piglets.

Enterococcus faecium inhibits NF-κB/NLRP3/Caspase-1 signaling pathway to antagonize enterotoxigenic Escherichia coli-mediated inflammatory response

Effects of a Probiotic, Enterococcus Faecium, on Growth Performance, Intestinal Morphology, Immune Response, and Cecal Microflora in Broiler Chickens Challenged with Escherichia Coli K88

L. Pseudomesenteroides and L. Johnsonii Isolated from Yaks in Tibet Modulate Gut Microbiota in Mice to Ameliorate Enteroinvasive Escherichia Coli-Induced Diarrhea.

Enterococcus faecium supplementation prevents enteritis caused by Escherichia coli in goats

Bifidobacterium Longum, Lactobacillus Plantarum and Pediococcus Acidilactici Reversed ETEC-Inducing Intestinal Inflammation in Mice

Probiotic Potential of Lactobacillus on the Intestinal Microflora Against Escherichia Coli Induced Mice Model Through High-Throughput Sequencing.

Escherichia Coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-κB-Mediated Activation of the MLCK-P-MLC Signaling Pathway.

<i>Enterococcus</i><i> faecium</i> C171: Modulating the Immune Response to Acute Lethal Viral Challenge

The protective effect of Escherichia coli Nissle 1917 on the intestinal barrier is mediated by inhibition of RhoA/ROCK2/MLC signaling via TLR-4

Lactobacillus salivarius WZ1 Inhibits the Inflammatory Injury of Mouse Jejunum Caused by Enterotoxigenic Escherichia coli K88 by Regulating the TLR4/NF-κB/MyD88 Inflammatory Pathway and Gut Microbiota

Enterococcus Faecium HDRsEf1 Protects the Intestinal Epithelium and Attenuates ETEC-Induced IL-8 Secretion in Enterocytes.

Effects of Probiotic Enterococcus faecium from Yak on the Intestinal Microflora and Metabolomics of Mice with Salmonella Infection

Bacillus Amyloliquefaciens TL106 Protects Mice Against Enterohaemorrhagic Escherichia Coli O157:H7-induced Intestinal Disease Through Improving Immune Response, Intestinal Barrier Function and Gut Microbiota.

A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model.

Enterococcus faecium Alleviates Gut Barrier Injury in C57BL/6 Mice with Dextran Sulfate Sodium-Induced Ulcerative Colitis

Lactiplantibacillus Plantarum YZX28 Alleviated Intestinal Barrier Dysfunction Induced by Enterotoxigenic Escherichia Coli Via Inhibiting Its Virulence Factor Production

Lactobacillus rhamnosus GR-1 Alleviates Escherichia coli-Induced Inflammation via NF-κB and MAPKs Signaling in Bovine Endometrial Epithelial Cells

Enterococcus Faecium NCIMB 10415 Administration Improves the Intestinal Health and Immunity in Neonatal Piglets Infected by Enterotoxigenic Escherichia Coli K88

Induction of Probiotic Strain Enterococcus Faecium EF1 on the Production of Cytokines, Superoxide Anion and Prostaglandin E2 in a Macrophage Cell Line

Bacillus amyloliquefaciens SC06 inhibits ETEC-induced pro-inflammatory responses by suppression of MAPK signaling pathways in IPEC-1 cells and diarrhea in weaned piglets

Lactobacillus plantarum and Lactobacillus brevis Alleviate Intestinal Inflammation and Microbial Disorder Induced by ETEC in a Murine Model